secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vir Biotechnology, Inc. (VIR)
CIK:        0001706431
Form:       8-K
Filed at:   2023-09-20T23:59:59+00:00
Accession:  0001193125-23-237943
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vir Biotechnology COO Johanna Friedl-Naderer to depart Sept 29; role not replaced
--------------------------------------------------------------------------------

- EVP and COO Johanna Friedl-Naderer will leave Vir Biotechnology on September 29, 2023.
- The COO role will not be filled; responsibilities assigned to other management team members.
- No successor has been named for the departing officer.
- Departure announced September 20, 2023, effective shortly thereafter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1706431/000119312523237943/0001193125-23-237943-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1706431/000119312523237943/d556596d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-237943

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer